Michael Gold
Corporate Officer/Principal at University of South Florida
Michael Gold active positions
| Companies | Position | Start | End |
|---|---|---|---|
| University of South Florida | Corporate Officer/Principal | - | - |
Career history of Michael Gold
Former positions of Michael Gold
| Companies | Position | Start | End |
|---|---|---|---|
| ALLON THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 2011-03-06 | 2012-12-23 |
Cerecin, Inc.
 Cerecin, Inc. Pharmaceuticals: MajorHealth Technology Cerecin, Inc. develops therapies to treat central nervous system disorders. It offers therapeutic treatments for Parkinson's disease, Alzheimer's disease, and other age-related memory loss disorders. The firm is also developing therapies that address metabolic deficiencies and provide an alternative energy source for brain cells. The company was founded in 2001 and is headquartered in Boulder, CO. | Chief Tech/Sci/R&D Officer | - | - |
Training of Michael Gold
| University of Miami | Doctorate Degree |
Statistics
International
| United States | 4 |
| Canada | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ALLON THERAPEUTICS INC. | Health Technology |
| Private companies | 1 |
|---|---|
Cerecin, Inc.
Cerecin, Inc. Pharmaceuticals: MajorHealth Technology Cerecin, Inc. develops therapies to treat central nervous system disorders. It offers therapeutic treatments for Parkinson's disease, Alzheimer's disease, and other age-related memory loss disorders. The firm is also developing therapies that address metabolic deficiencies and provide an alternative energy source for brain cells. The company was founded in 2001 and is headquartered in Boulder, CO. | Health Technology |
- Stock Market
- Insiders
- Michael Gold
- Experience
